Litigation Details for Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2020)
✉ Email this page to a colleague
Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-04-15 |
| Court | District Court, D. Delaware | Date Terminated | 2020-07-28 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | PURDUE PHARMA L.P. | ||
| Patents | 10,369,109; 10,407,434 | ||
| Attorneys | Rodger Dallery Smith , II | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Details for Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-04-15 | 1 | Complaint | United States Patent Nos. 10,407,434 (the “’434 patent”) and 10,369,109 (the “’109 patent”) (collectively…RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 10,369,109) 53. …. This is an action for patent infringement arising under the patent laws of the United States, … that Defendants have infringed the patents-in- suit. The patents-in-suit are listed in the FDA Approved… THE PATENTS-IN-SUIT THE ’434 PATENT 37. Purdue and | External link to document |
| 2020-07-28 | 14 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,407,434 B2; 10,369,109 B2. (Attachments…2020 28 July 2020 1:20-cv-00515 830 Patent None District Court, D. Delaware | External link to document |
| 2020-04-15 | 3 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,407,434 B2; 10,369,109 B2. (nmg) (…2020 28 July 2020 1:20-cv-00515 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
